Literature DB >> 26135487

Abulia following an episode of cardiac arrest.

Vismay Dinesh Naik1.   

Abstract

The word 'abulia' means a lack of will, initiative or drive. The symptoms of abulia include lack of spontaneous action and speech, reduced emotional responsiveness and social interaction, poor attention and easy distractibility. These symptoms are independent of reduced levels of consciousness or cognitive impairment. We describe a case of a socially active 72-year-old female patient who presented with symptoms of abulia which may have occurred due to damage of the frontosubcortical circuits following an episode of cardiac arrest. The patient's symptoms improved dramatically following treatment with bromocriptine. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26135487      PMCID: PMC4493212          DOI: 10.1136/bcr-2015-209357

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Apathy: why care?

Authors:  Robert van Reekum; Donald T Stuss; Laurie Ostrander
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

2.  Abulia: no will, no way.

Authors:  S M Hastak; Pooja S Gorawara; N K Mishra
Journal:  J Assoc Physicians India       Date:  2005-09

3.  Treating organic abulia with bromocriptine and lisuride: four case studies.

Authors:  K Barrett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

4.  Motivational deficits after brain injury: effects of bromocriptine in 11 patients.

Authors:  J H Powell; S al-Adawi; J Morgan; R J Greenwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  The effect of bromocriptine on speech dysfunction in patients with diffuse brain injury (akinetic mutism).

Authors:  M L Crismon; A Childs; R E Wilcox; N Barrow
Journal:  Clin Neuropharmacol       Date:  1988-10       Impact factor: 1.592

6.  N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.

Authors:  R Van Reekum; M Bayley; S Garner; I M Burke; S Fawcett; A Hart; W Thompson
Journal:  Brain Inj       Date:  1995-01       Impact factor: 2.311

7.  Akinetic mutism: pharmacologic probe of the dopaminergic mesencephalofrontal activating system.

Authors:  H C Echiverri; W O Tatum; T A Merens; S B Coker
Journal:  Pediatr Neurol       Date:  1988 Jul-Aug       Impact factor: 3.372

8.  Bupropion in the management of apathy.

Authors:  C Corcoran; M L Wong; V O'Keane
Journal:  J Psychopharmacol       Date:  2004-03       Impact factor: 4.153

Review 9.  Frontal-subcortical circuits and human behavior.

Authors:  J L Cummings
Journal:  Arch Neurol       Date:  1993-08

10.  Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest.

Authors:  Joshua C Reynolds; Jon C Rittenberger; Clifton W Callaway
Journal:  Resuscitation       Date:  2012-11-21       Impact factor: 5.262

View more
  1 in total

1.  Aboulia: Where There is a Will There is a Way.

Authors:  Srimathy Narasimhan; Shankar Balakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2020-09-25       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.